IP Library Granted Patent US 7,622,252
Granted Patent B2
US 7,622,252 · App. 11/448,590 · Granted Nov 24, 2009

Generation of minicircle DNA with physiological supercoiling

Assignees: Baylor College of Medicine; The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,622,252
App. No.
11/448,590
Granted
Nov 24, 2009
Kind
B2
Abstract

Methods for the production of supercoiled DNA minicircles and their use as substrates are described herein.

Claims (26)

1. A method for producing supercoiled DNA minicircles, comprising:

a) engineering a plasmid DNA molecule comprising site-specific recombination sites;

b) transforming the plasmid into a cell suitable for site-specific recombination to occur, under conditions such that topoisomerase IV decatenation activity is inhibited, thereby producing a plurality of catenated DNA circles, wherein at least one of the circles in each catenane is a supercoiled DNA minicircle of less than about 1 kb in size;

c) decatenating the catenated site-specific recombination products, thereby releasing the supercoiled DNA minicircles from the catenanes; and

d) isolating the supercoiled DNA minicircles.

2. The method of claim 1 , wherein the catenated site-specific recombination products are decatenated by a site-specific endonuclease that does not cleave the supercoiled DNA minicircles.

3. The method of claim 1 , wherein nicked minicircles are also produced, and wherein the supercoiled DNA minicircles are separated from the nicked DNA minicircles.

4. The method of claim 1 , wherein the site-specific recombination sites are selected from the group consisting of: attB, attP, loxP sites, γδ res sites, FRT sites, hixL, hixR, TN3 res sites, Tn21 res sites, psi sites and cer sites.

5. The method of claim 1 , wherein the site-specific recombination utilizes an enzyme selected from the group consisting of: γδ resolvase, Hin recombinase, P1 Cre, yeast 2 micron Flp, Tn3 resolvase, Tn21 resolvase, λ integrase and XerCD.

6. The method of claim 1 , wherein the minicircles comprise one or more putative binding sites for one or more proteins of interest.

7. The method of claim 6 , wherein the one or more proteins of interest are selected from the group consisting of: topoisomerases, site-specific recombinases, restriction endonucleases, transcription factors, remodeling factors, DNA bending proteins, helicases, polymerases and DNA repair proteins.

8. The method of claim 1 , wherein the supercoiled DNA minicircle is attached to a solid support matrix.

9. The method of claim 1 , wherein topoisomers of the supercoiled minicircles are separated from each other, thereby producing substantially purified DNA minicircles, wherein the DNA minicircles have the same linking number.

10. The method of claim 9 , wherein the DNA minicircles have a ΔLk of between about +6 to about −6.

11. The method of claim 10 , wherein the DNA minicircles have a ΔLk of between about −1 to about −6.

12. The method of claim 1 , wherein the site-specific recombination sites are separated by about 100 base pairs to about 1000 base pairs.

13. The method of claim 12 , wherein the site-specific recombination sites are separated by about 342 base pairs.

14. A method for producing a population of supercoiled DNA minicircles

a) engineering a plasmid DNA molecule comprising site-specific recombination sites;

b) transforming the plasmid into a cell suitable for site-specific recombination to occur, under conditions such that topoisomerase IV decatenation activity is inhibited, thereby producing a plurality of catenated DNA circles, wherein at least one of the circles in each catenane is a supercoiled DNA minicircle of less than about 1 kb in size;

c) recovering the supercoiled DNA minicircles from the cell;

d) treating the supercoiled DNA minicircles with an enzyme that introduces nicks into the DNA minicircle; and

e) ligating the nicked minicircle in the presence of a DNA intercalator that introduces supercoils,

thereby producing a population of supercoiled DNA minicircles.

15. The method of claim 14 , wherein the enzyme that introduces nicks into the DNA minicircle is a nicking endonuclease.

16. The method of claim 14 , wherein the DNA intercalator is ethidium bromide.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jan 28, 2011
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025771/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2007
From: PERONA, JOHN J.; FOGG, JONATHON
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 018821/0403 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2007
From: ZECHIEDRICH, E. LYNN
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 018822/0136 →
Continuity (2)
Provisional Application 6068929800 · Jun 10, 2005
Related Publication 20070020659A1 · Jan 25, 2007